Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
16h
New Scientist on MSNStrongest evidence yet that Ozempic and Wegovy reduce alcohol intakeThe drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.
The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results